Skip to main content
Top
Published in: Gastric Cancer 3/2013

01-07-2013 | Letter to the Editor

Laparoscopy-assisted proximal gastrectomy for early gastric cancer is an ugly duckling with unsolved concerns: oncological safety, late complications, and functional benefit

Authors: Sang-Hoon Ahn, Ju Hee Lee, Do Joong Park, Hyung-Ho Kim

Published in: Gastric Cancer | Issue 3/2013

Login to get access

Excerpt

There are notable changes in that the proportion of early gastric cancer (EGC) and proximal gastric cancer has increased continuously during the past 20 years, from 24.8 % to nearly 50 % and from 5.3  to 14.0 %, respectively. Proximal EGC consists of 30.3 % of all proximal gastric cancer whereas distal EGC consists of 51.5 % of all distal gastric cancer [13]. Accordingly, more and more surgeons are interested in laparoscopic gastrectomy for early gastric cancer. In proximal EGC and the concept of minimally invasive surgery, laparoscopy-assisted proximal gastrectomy (LAPG) is a theoretically better treatment option than others [i.e., open proximal gastrectomy, open total gastrectomy, and laparoscopy-assisted total gastrectomy (LATG)]. However, LAPG is not popular these days. Even including the open cases, proximal gastrectomy was performed in only 141 (1.0 %) patients in 2009 [2]. Proximal gastrectomy (PG) is not yet the standard treatment for patients with proximal early gastric cancer (EGC): it is still classified as an investigational treatment by the Japanese gastric cancer treatment guidelines [4]. The application of proximal gastrectomy to proximal EGC has been limited by the following three main concerns. The first is oncological concern, mainly focused on limited lymph node dissection; the second is late complications such as reflux esophagitis and anastomotic stricture, related to reconstruction methods; and the third is functional benefits. …
Literature
1.
go back to reference Ahn HS, Lee HJ, Yoo MW, Jeong SH, Park DJ, Kim HH, Kim WH, Lee KU, Yang HK. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011;98(2):255–60.PubMedCrossRef Ahn HS, Lee HJ, Yoo MW, Jeong SH, Park DJ, Kim HH, Kim WH, Lee KU, Yang HK. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011;98(2):255–60.PubMedCrossRef
2.
go back to reference Jeong O, Park Y-K. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011;11(2):69–77.PubMedCrossRef Jeong O, Park Y-K. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011;11(2):69–77.PubMedCrossRef
3.
go back to reference Kim HH, KLASS (Korean Laparoscopic Gastrointestinal Surgery Study Group). 2004 Nationwide Gastric Cancer Survey in Korea. J Gastric Cancer 2005;5(4):285–303. Kim HH, KLASS (Korean Laparoscopic Gastrointestinal Surgery Study Group). 2004 Nationwide Gastric Cancer Survey in Korea. J Gastric Cancer 2005;5(4):285–303.
4.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14(2):113–23. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14(2):113–23.
5.
go back to reference Wen L, Chen XZ, Wu B, Chen XL, Wang L, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, et al. Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology. 2012;59(114):633–40.PubMed Wen L, Chen XZ, Wu B, Chen XL, Wang L, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, et al. Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology. 2012;59(114):633–40.PubMed
6.
go back to reference Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg. 2010;251(3):417–20.PubMedCrossRef Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg. 2010;251(3):417–20.PubMedCrossRef
7.
go back to reference Hwang SH, do Park J, Jee YS, Kim MC, Kim HH, Lee HJ, Yang HK, Lee KU. Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg. 2009;144(6):559–64. discussion 565.PubMedCrossRef Hwang SH, do Park J, Jee YS, Kim MC, Kim HH, Lee HJ, Yang HK, Lee KU. Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg. 2009;144(6):559–64. discussion 565.PubMedCrossRef
8.
go back to reference Kim W, Song KY, Lee HJ, Han SU, Hyung WJ, Cho GS. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg. 2008;248(5):793–9.PubMedCrossRef Kim W, Song KY, Lee HJ, Han SU, Hyung WJ, Cho GS. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg. 2008;248(5):793–9.PubMedCrossRef
9.
go back to reference Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci. 2007;52(2):543–8.PubMedCrossRef Kim MC, Jung GJ, Kim HH. Morbidity and mortality of laparoscopy-assisted gastrectomy with extraperigastric lymph node dissection for gastric cancer. Dig Dis Sci. 2007;52(2):543–8.PubMedCrossRef
10.
go back to reference Ahn SH, Lee JH, Park DJ, Kim HH. Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer. 2012 [Epub ahead of print] Ahn SH, Lee JH, Park DJ, Kim HH. Comparative study of clinical outcomes between laparoscopy-assisted proximal gastrectomy (LAPG) and laparoscopy-assisted total gastrectomy (LATG) for proximal gastric cancer. Gastric Cancer. 2012 [Epub ahead of print]
11.
go back to reference Eom BW, Kim YW, Lee SE, Ryu KW, Lee JH, Yoon HM, Cho SJ, Kook MC, Kim SJ. Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc. 2012;26(11):3273–81PubMedCrossRef Eom BW, Kim YW, Lee SE, Ryu KW, Lee JH, Yoon HM, Cho SJ, Kook MC, Kim SJ. Survival and surgical outcomes after laparoscopy-assisted total gastrectomy for gastric cancer: case-control study. Surg Endosc. 2012;26(11):3273–81PubMedCrossRef
12.
go back to reference Lee JH, Ahn SH, Park DJ, Kim HH, Lee HJ, Yang HK. Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg. 2012;36(10):2394–9PubMedCrossRef Lee JH, Ahn SH, Park DJ, Kim HH, Lee HJ, Yang HK. Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg. 2012;36(10):2394–9PubMedCrossRef
13.
go back to reference Adachi Y, Inoue T, Hagino Y, Shiraishi N, Shimoda K, Kitano S. Surgical results of proximal gastrectomy for early-stage gastric cancer: jejunal interposition and gastric tube reconstruction. Gastric Cancer. 1999;2(1):40–5.PubMedCrossRef Adachi Y, Inoue T, Hagino Y, Shiraishi N, Shimoda K, Kitano S. Surgical results of proximal gastrectomy for early-stage gastric cancer: jejunal interposition and gastric tube reconstruction. Gastric Cancer. 1999;2(1):40–5.PubMedCrossRef
14.
go back to reference Takeshita K, Saito N, Saeki I, Honda T, Tani M, Kando F, Endo M. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: surgical techniques and evaluation of postoperative function. Surgery (St. Louis). 1997;121(3):278–86.CrossRef Takeshita K, Saito N, Saeki I, Honda T, Tani M, Kando F, Endo M. Proximal gastrectomy and jejunal pouch interposition for the treatment of early cancer in the upper third of the stomach: surgical techniques and evaluation of postoperative function. Surgery (St. Louis). 1997;121(3):278–86.CrossRef
15.
go back to reference Furukawa H, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ohigashi H, Nakano H, Yasuda T. Limited surgery for early gastric cancer in cardia. Ann Surg Oncol. 1998;5(4):338–41.PubMedCrossRef Furukawa H, Hiratsuka M, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ohigashi H, Nakano H, Yasuda T. Limited surgery for early gastric cancer in cardia. Ann Surg Oncol. 1998;5(4):338–41.PubMedCrossRef
16.
go back to reference Kameyama J, Ishida H, Yasaku Y, Suzuki A, Kuzu H, Tsukamoto M. Proximal gastrectomy reconstructed by interposition of a jejunal pouch. Surgical technique. Eur J Surg. 1993;159(9):491–3.PubMed Kameyama J, Ishida H, Yasaku Y, Suzuki A, Kuzu H, Tsukamoto M. Proximal gastrectomy reconstructed by interposition of a jejunal pouch. Surgical technique. Eur J Surg. 1993;159(9):491–3.PubMed
17.
go back to reference An JY, Youn HG, Choi MG, Noh JH, Sohn TS, Kim S. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg. 2008;196(4):587–91.PubMedCrossRef An JY, Youn HG, Choi MG, Noh JH, Sohn TS, Kim S. The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg. 2008;196(4):587–91.PubMedCrossRef
18.
go back to reference Yoo CH, Sohn BH, Han WK, Pae WK. Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach. Cancer Res Treat. 2004;36(1):50–5.PubMedCrossRef Yoo CH, Sohn BH, Han WK, Pae WK. Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach. Cancer Res Treat. 2004;36(1):50–5.PubMedCrossRef
19.
go back to reference Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Hasumi A. Completely laparoscopic proximal gastrectomy with jejunal interposition and lymphadenectomy. J Am Coll Surg. 2000;191(1):114–9.PubMedCrossRef Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Hasumi A. Completely laparoscopic proximal gastrectomy with jejunal interposition and lymphadenectomy. J Am Coll Surg. 2000;191(1):114–9.PubMedCrossRef
20.
go back to reference Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M. Laparoscopic proximal gastrectomy with jejunal interposition for gastric cancer in the proximal third of the stomach: a retrospective comparison with open surgery. Surg Endosc. 2013;27(1):146–53PubMedCrossRef Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M. Laparoscopic proximal gastrectomy with jejunal interposition for gastric cancer in the proximal third of the stomach: a retrospective comparison with open surgery. Surg Endosc. 2013;27(1):146–53PubMedCrossRef
21.
go back to reference Kitamura K, Yamaguchi T, Nishida S, Yamamoto K, Ichikawa D, Okamoto K, Taniguchi H, Hagiwara A, Sawai K, Takahashi T. The operative indications for proximal gastrectomy in patients with gastric cancer in the upper third of the stomach. Surg Today. 1997;27(11):993–8.PubMedCrossRef Kitamura K, Yamaguchi T, Nishida S, Yamamoto K, Ichikawa D, Okamoto K, Taniguchi H, Hagiwara A, Sawai K, Takahashi T. The operative indications for proximal gastrectomy in patients with gastric cancer in the upper third of the stomach. Surg Today. 1997;27(11):993–8.PubMedCrossRef
22.
go back to reference Kaminishi M, Takubo K, Mafune K. The diversity of gastric cancer: pathogenesis, diagnosis and therapy. Berlin: Springer; 2005. p 263 Kaminishi M, Takubo K, Mafune K. The diversity of gastric cancer: pathogenesis, diagnosis and therapy. Berlin: Springer; 2005. p 263
23.
go back to reference Kwon SJ. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg. 1997;21(8):837–44.PubMedCrossRef Kwon SJ. Prognostic impact of splenectomy on gastric cancer: results of the Korean Gastric Cancer Study Group. World J Surg. 1997;21(8):837–44.PubMedCrossRef
24.
go back to reference Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schroder W, Thiele J, Dienes HP, Holscher AH. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76(2):89–92.PubMedCrossRef Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schroder W, Thiele J, Dienes HP, Holscher AH. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001;76(2):89–92.PubMedCrossRef
25.
go back to reference Shin SH, Jung H, Choi SH, An JY, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol. 2009;16(5):1304–9.PubMedCrossRef Shin SH, Jung H, Choi SH, An JY, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol. 2009;16(5):1304–9.PubMedCrossRef
26.
go back to reference Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14(2):97–100.PubMedCrossRef Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14(2):97–100.PubMedCrossRef
Metadata
Title
Laparoscopy-assisted proximal gastrectomy for early gastric cancer is an ugly duckling with unsolved concerns: oncological safety, late complications, and functional benefit
Authors
Sang-Hoon Ahn
Ju Hee Lee
Do Joong Park
Hyung-Ho Kim
Publication date
01-07-2013
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 3/2013
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-013-0245-y

Other articles of this Issue 3/2013

Gastric Cancer 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.